Published in Virology on July 30, 1981
Dynamics of viral RNA synthesis during measles virus infection. J Virol (2005) 1.44
Mutation of the TYTLE motif in the cytoplasmic tail of the sendai virus fusion protein deeply affects viral assembly and particle production. PLoS One (2013) 0.77
Evidence that Receptor Destruction by the Sendai Virus Hemagglutinin-Neuraminidase Protein Is Responsible for Homologous Interference. J Virol (2016) 0.76
The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol (1993) 6.38
Osteomyelitis. N Engl J Med (1997) 3.89
Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med (1970) 3.74
A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. EMBO J (1995) 3.63
Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited. J Virol (1998) 3.60
Osteomyelitis: the past decade. N Engl J Med (1980) 3.48
Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis (1982) 3.36
Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc Natl Acad Sci U S A (1991) 3.15
Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis (1988) 3.09
Molecular cloning of natural paramyxovirus copy-back defective interfering RNAs and their expression from DNA. Virology (1992) 2.89
An unusual infection due to staphylococcus aureus. N Engl J Med (1971) 2.68
Gentamicin antibacterial activity in the presence of human polymorphonuclear leukocytes. Antimicrob Agents Chemother (1979) 2.42
Risk factors for a medically inappropriate admission to a Department of Internal Medicine. Arch Intern Med (1997) 2.19
Modulation of cytosolic-free calcium transients by changes in intracellular calcium-buffering capacity: correlation with exocytosis and O2-production in human neutrophils. J Cell Biol (1984) 2.15
Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest (1984) 2.11
Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. 3. Osteomyelitis associated with vascular insufficiency. N Engl J Med (1970) 2.05
Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis. J Infect Dis (1984) 2.02
Sequence determination of the Sendai virus HN gene and its comparison to the influenza virus glycoproteins. Cell (1985) 2.01
Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect Immun (1991) 1.99
The Sendai paramyxovirus accessory C proteins inhibit viral genome amplification in a promoter-specific fashion. J Virol (1996) 1.94
Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. J Infect Dis (1991) 1.89
Host factors selectively increase staphylococcal adherence on inserted catheters: a role for fibronectin and fibrinogen or fibrin. J Infect Dis (1989) 1.87
Adsorption of fibronectin onto polymethylmethacrylate and promotion of Staphylococcus aureus adherence. Infect Immun (1984) 1.86
Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tuber Lung Dis (2000) 1.83
Quantitative analysis of the cytosolic free calcium dependency of exocytosis from three subcellular compartments in intact human neutrophils. J Cell Biol (1986) 1.82
Molecular cloning of the 3'-proximal third of Sendai virus genome. Proc Natl Acad Sci U S A (1983) 1.73
Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1990) 1.68
Inhibition of Sendai virus genome replication due to promoter-increased selectivity: a possible role for the accessory C proteins. J Virol (1997) 1.59
Chemotactic peptide activation of human neutrophils and HL-60 cells. Pertussis toxin reveals correlation between inositol trisphosphate generation, calcium ion transients, and cellular activation. J Clin Invest (1985) 1.58
The activity of Sendai virus genomic and antigenomic promoters requires a second element past the leader template regions: a motif (GNNNNN)3 is essential for replication. J Virol (1998) 1.52
Role of defective interfering particles of Sendai virus in persistent infections. Virology (1979) 1.52
Phorbol myristate acetate stimulates ATP-dependent calcium transport by the plasma membrane of neutrophils. J Clin Invest (1984) 1.51
Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of France. Am J Respir Crit Care Med (2000) 1.51
Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob Agents Chemother (1991) 1.50
Foreign body infection: role of fibronectin as a ligand for the adherence of Staphylococcus aureus. J Infect Dis (1984) 1.49
Impact of a public campaign on pre-hospital delay in patients reporting chest pain. Heart (1996) 1.47
Analysis of the Sendai virus M gene and protein. J Virol (1984) 1.46
Pigmentation-associated glycoprotein of human melanomas and melanocytes: definition with a mouse monoclonal antibody. J Invest Dermatol (1985) 1.39
Addition of high-mannose sugars must precede disulfide bond formation for proper folding of Sendai virus glycoproteins. J Virol (1989) 1.35
Fibronectin is more active than fibrin or fibrinogen in promoting Staphylococcus aureus adherence to inserted intravascular catheters. J Infect Dis (1993) 1.34
Functional characterisation of the genomic and antigenomic promoters of Sendai virus. Virology (1995) 1.33
Instability of the viral M protein in BHK-21 cells persistently infected with Sendai virus. Cell (1982) 1.32
New resistance in Staphylococcus aureus. N Engl J Med (1999) 1.30
Isolation of RNA transcripts from the entire Sendai viral genome. J Virol (1975) 1.29
Comparison of immunological methods for diagnosis of pneumococcal pneumonia in biological fluids. Eur J Clin Microbiol (1987) 1.25
Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis. J Infect Dis (1982) 1.25
Budding efficiency of Sendai virus nucleocapsids: influence of size and ends of the RNA. Virus Res (1989) 1.24
Susceptibility of Staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics. Antimicrob Agents Chemother (1993) 1.23
Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects (second of three parts). N Engl J Med (1970) 1.23
Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa. J Infect Dis (1986) 1.19
The efficiency of Sendai virus genome replication: the importance of the RNA primary sequence independent of terminal complementarity. Virology (1996) 1.19
The major glycoprotein of Sendai virus is dispensable for efficient virus particle budding. J Gen Virol (1991) 1.15
Gentamicin inactivation in purulent exudates: role of cell lysis. J Infect Dis (1980) 1.13
Structure-function analysis of the Sendai virus F and HN cytoplasmic domain: different role for the two proteins in the production of virus particle. Virology (2000) 1.13
Collagenolytic activity of bacteria. J Bacteriol (1969) 1.11
Molecular cloning and characterization of a Sendai virus internal deletion defective RNA. J Gen Virol (1993) 1.10
"Rule of six": how does the Sendai virus RNA polymerase keep count? J Virol (2001) 1.08
Short-term administration of rifampin in the prevention or eradication of infection due to foreign bodies. Rev Infect Dis (1983) 1.07
Attachment of Staphylococcus aureus to polymethylmethacrylate increases its resistance to phagocytosis in foreign body infection. Infect Immun (1985) 1.07
Role of host and bacterial factors in modulating staphylococcal adhesion to implanted polymer surfaces. J Biomater Appl (1990) 1.05
Intracellular stability of nonreplicating paramyxovirus nucleocapsids. Virology (1990) 1.05
Predictors of inappropriate hospital days in a department of internal medicine. Int J Epidemiol (1998) 1.05
Drastic immunoreactivity changes between the immature and mature forms of the Sendai virus HN and F0 glycoproteins. J Virol (1986) 1.04
The Sendai virus matrix protein appears to be recruited in the cytoplasm by the viral nucleocapsid to function in viral assembly and budding. J Gen Virol (1994) 1.04
Protein turnover and proliferation. Turnover kinetics associated with the elevation of 3T3-cell acid-proteinase activity and cessation of net protein gain. Biochem J (1982) 1.04
Protein kinase associated with Sendai virions. J Virol (1974) 1.03
Role of cytosolic free calcium and phospholipase C in leukotriene-B4-stimulated secretion in human neutrophils. Comparison with the chemotactic peptide formyl-methionyl-leucyl-phenylalanine. Eur J Biochem (1987) 1.02
Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions. J Clin Invest (1979) 1.02
Characterisation of the pncA gene in Mycobacterium tuberculosis isolates from Gauteng, South Africa. Int J Tuberc Lung Dis (2001) 1.01
Magnitude of bacteremia and complement activation during Neisseria meningitidis infection: study of two co-primary cases with different clinical presentations. Eur J Clin Microbiol (1984) 1.01
Methicillin-resistant strains of Staphylococcus aureus: relation between expression of resistance and phagocytosis by polymorphonuclear leukocytes. J Infect Dis (1979) 1.01
To control or not to control colonization with MRSA ... that's the question! QJM (1997) 1.01
A Sendai virus vector leading to the efficient expression of mutant M proteins interfering with virus particle budding. Virology (1996) 1.00
Comparison of PCR-heteroduplex characterization by automated DNA sequencing and line probe assay for the detection of rifampicin resistance in Mycobacterium tuberculosis isolates from KwaZulu-Natal, South Africa. Microb Drug Resist (1998) 1.00
Neutrophil bactericidal activity against Staphylococcus aureus adherent on biological surfaces. Surface-bound extracellular matrix proteins activate intracellular killing by oxygen-dependent and -independent mechanisms. J Clin Invest (1990) 1.00
Adenosine triphosphate-dependent calcium pump in the plasma membrane of guinea pig and human neutrophils. J Clin Invest (1984) 0.97
Successful single-dose prophylaxis of Staphylococcus aureus foreign body infections in guinea pigs by fleroxacin. Antimicrob Agents Chemother (1990) 0.97
Bilateral acute retinal necrosis (BARN). Identification of the presumed infectious agent. Ophthalmology (1984) 0.95
Use of quinolones in osteomyelitis and infected orthopaedic prosthesis. Drugs (1999) 0.95
Synergistic effect of quinolones and oxacillin on methicillin-resistant Staphylococcus species. Antimicrob Agents Chemother (1989) 0.95
Contribution of tumor necrosis factor to host defense against staphylococci in a guinea pig model of foreign body infections. J Infect Dis (1992) 0.95
Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1994) 0.94
In vitro activity of a new semisynthetic cephalosporin: cefoperazone. Clin Ther (1980) 0.93
Comparative efficacies of imipenem, oxacillin and vancomycin for therapy of chronic foreign body infection due to methicillin-susceptible and -resistant Staphylococcus aureus. J Antimicrob Chemother (1994) 0.93
In vitro efficacy of several antibiotics against intracellular S. aureus in chronic granulomatous disease. Helv Paediatr Acta (1983) 0.92
Typhoid fever imported from Mexico to Switzerland. Studies on R factor mediated chloramphenicol resistance. J Hyg (Lond) (1973) 0.91
Comparative superoxide-generating system of granulocytes from blood and peritoneal exudates. Infect Immun (1984) 0.90
Quinolones and osteomyelitis: state-of-the-art. Drugs (1995) 0.89
Viral genome synthesis in BHK 21 cells persistently infected with Sendai virus. Virology (1980) 0.88
Demonstration of a local exhaustion of complement components and of an enzymatic degradation of immunoglobulins in pleural empyema: a possible factor favouring the persistence of local bacterial infections. Clin Exp Immunol (1980) 0.88
Defective interfering particles of Sendai virus modulate HN expression at the surface of infected BHK cells. Virology (1983) 0.88
Sulfated N-linked oligosaccharides in mammalian cells. II. Identification of glycosaminoglycan-like chains attached to complex-type glycans. J Biol Chem (1988) 0.87
Cleavage of C3 by neutral proteases from granulocytes in pleural empyema. J Infect Dis (1981) 0.87
[Delay in management and treatment of patients with suspected acute myocardial infarction: role of the public, of extra- and intra-hospital structures and transportation methods]. Schweiz Med Wochenschr (1993) 0.86